Biotinylated Anti-Human GRO-α/MGSA (CXCL1) 0 ReviewsSubmit a Review Product Details Catalog Number: 500-P92BT Description: Source: Polyclonal Rabbit Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human GRO-alpha/MGSA (CXCL1). Anti-Human GRO-alpha/MGSA (CXCL1)-specific antibody was purified by affinity chromatography and then biotinylated. Immunogen: E.coli derived Recombinant Human GRO-α/MGSA (CXCL1) (PeproTech catalog# 300-11) Sandwich ELISA: To detect Human GRO-α/MGSA by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.25 – 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech’s Polyclonal Anti-Human GRO-α/MGSA (500-P92) as a capture antibody, allows the detection of at least 0.2 – 0.4 ng/well of recombinant Human GRO-α/MGSA. Western Blot: To detect Human GRO-α/MGSA by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant Human GRO-α/MGSA is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions. Note: 1mg will be provided as 2x500μg. Cross Reactivity Cited in References: Human References SDS CoA Search Product Line Country Of Origin: USA Not for human use. Research Interest Angiogenesis/Cardiovascular Chemotaxis Inflammation Neurobiology Wound Healing Recent Citations First Author Bouhaddou, M Title The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Citation Cell; 182(3) pg685-712.e19 PubMed ID 32645325 First Author Øynebråten, I Title Characterization of a novel chemokine-containing storage granule in endothelial cells: evidence for preferential exocytosis mediated by protein kinase A and diacylglycerol. Citation Journal of immunology (Baltimore, Md. : 1950); 175(8) pg5358-69 PubMed ID 16210642